期刊文献+

首发精神分裂症脑脊液和血清细胞因子水平及其与临床特征的关系 被引量:8

下载PDF
导出
摘要 目的检测首发精神分裂症患者脑脊液和血清细胞因子水平,探讨其与临床特征的关系。方法纳入42例首发未用药的精神分裂症患者,采用放射免疫法测定患者脑脊液和血清白细胞介素2(IL-2)、白细胞介素6(IL-6)和肿瘤坏死因子-α(TNF-α)的浓度,采用阳性和阴性症状量表(PANSS)评定其精神症状,脑脊液对照组为10例外科手术患者,血清对照组为试剂盒提供正常的健康者血清细胞因子浓度。结果患者组脑脊液和血清IL-2和TNF-α水平均显著低于对照组(P<0.05),脑脊液IL-6水平高于对照组(P<0.05),血清IL-6与对照组的差异无统计学意义(P>0.05)。患者组脑脊液和血清IL-2、IL-6和TNF-α水平与年龄、体重、病程、PANSS总分及其分量表分等的相关均无统计学意义(P>0.05),而血清TNF-α水平与发病年龄呈正相关(r=0.37,P<0.05)。结论首发精神分裂症患者中枢和外周均存在细胞免疫障碍,但未发现其与临床症状相关,血清TNF-α水平与精神分裂症早期发病可能密切相关。
出处 《中国神经精神疾病杂志》 CAS CSCD 北大核心 2007年第8期480-481,共2页 Chinese Journal of Nervous and Mental Diseases
基金 广州市医药卫生科技项目基金资助(2004年)
  • 相关文献

参考文献10

  • 1朱海兵,广州市精神病医院,郭扬波,广州市精神病医院,马崔,广州市精神病医院.白细胞介素-2与精神分裂症研究进展[J].国外医学(精神病学分册),2000,27(3):189-192. 被引量:17
  • 2朱海兵,侯静,殷青云,胡号应,马崔,郭扬波.精神分裂症血清白细胞介素-2测定及其临床意义[J].中国神经精神疾病杂志,2002,28(3):221-222. 被引量:3
  • 3Licinio J,Seibyl JP,Altemus M,et al.Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients.Am J Psychiatry,1993,150(9):1408.
  • 4Barak V,Barak Y,Levine J,et al.Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients.J Basic Clin Physiol Pharmacol,1995,6 (1):61.
  • 5El-Mallakh RS,Suddath RL,Wyatt RJ.Interleukin-1 alpha and interleukin-2 in cerebrospinal fluid of schizophrenic subjects.Prog Neuropsychopharmacol Biol Psychiatry,1993,17 (3):383.
  • 6Paterson GJ,Ohashi Y,Reynolds GP,et al.Selective increases in the cytokine,TNF {alpha},in the prefrontal cortex of PCP-treated rats and human schizophrenic subjects:influence of antipsychotic drugs.J Psychopharmacol,2006,20(5):636.
  • 7卢山,刘刚,孔祥泉,陈胜洪,陈继军,)姚咏明.首发精神分裂症患者中枢细胞因子的实验室研究[J].中国心理卫生杂志,2003,17(3):206-206. 被引量:4
  • 8Van Kammen DP,McAllister-Sistilli CG,Kelley ME,et al.Elevated interleukin-6 in schizophrenia.Psychiatry Res,1999,87 (2-3):129.
  • 9朱海兵,马崔,侯静,殷青云,胡号应,郭扬波.精神分裂症患者治疗前后血清白介素-6和α-干扰素的研究[J].中国神经精神疾病杂志,2002,28(5):324-326. 被引量:5
  • 10Muller N,Riedel M,Ackenheil M,et al.The role of immune function in schizophrenia:an overview.Eur Arch Psychiatry Clin Neurosci,1999,249(S4):62.

二级参考文献19

  • 1[1]Mallakh RS , Suddath RL , Wyatt RJ . Interleukin-1 alpha and interleukin-2 in cerebrospinal fluid of schizophrenic subjects .Prog Neuropsychopharmacol Biol Psychiatry,1993,17:383-391.
  • 2[2]Barak V ,Barak Y ,Levine J, et al .Changes in interleukin-1 beta and soluble interleukin-2 receptor levels in CSF and serum of schizophrenic patients. J Basic Clin Physiol pharmacol . 1995,6:61-69.
  • 3[3]Licinio J ,Seibyl JP , Altemus M,et al . Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients. Am J Psychiatry,1993,150:1408-1412.
  • 4[4]Muller N , Riedel M , Ackenheil M,et al . The role immune function in schizophrenia : an overview.Eur Arch Psychiatry Clin Neurosci,1999,249(suppl.4):62-68.
  • 5Lin A, Kenis G, Bignotti S, et al. The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6.Schizophr Res, 1998,32(1):9.
  • 6Akiyama K. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophr Res, 1999,37(1):97.
  • 7Kim YK, Lee MS, Suh KY. Decreased interleukin-2 production in Korean schizophrenic patients. Biol Psychiatry. 1998,43(9):701.
  • 8Waltrip RW, Carrigan DR, Carpenter WT, et al. Immunopathology and viral reactivation. A general theory of schizophrenia. J Nerv Ment Dis 1990,178(12) :729.
  • 9Maes M, Bosmans E, Ranjan R, et al. Lower plasma cc16, anatural antiinflammatory protein, and increased plasma interleukin-1 recepro antagonist in schizophrenia: effects of antipsychotic drugs. Schizophre Res,1996, 21(1): 39.
  • 10Ganguli R, Yang ZW, Shurin G, et al. Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res, 1994,51(1):1.

共引文献24

同被引文献106

引证文献8

二级引证文献67

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部